Effects of probucol on homozygous cases of familial hypercholesterolemia
- PMID: 6615580
- DOI: 10.1016/0021-9150(83)90102-8
Effects of probucol on homozygous cases of familial hypercholesterolemia
Abstract
A marked reduction of serum cholesterol was obtained by treatment with probucol in heterozygous as well as in homozygous cases of familial hypercholesterolemia. A strict dietary regimen (low-fat, low-calories) intensified the hypocholesterolemic effect of the drug. The drug was also useful in diminishing the rebound of serum cholesterol after plasma exchange. Probucol reduced serum triglycerides in heterozygous cases of familial hypercholesterolemia, but there was a slight increase in triglycerides in homozygous cases. Treatment with probucol resulted in the regression of cutaneous and tendon xanthomas. Although it caused a decrease in HDL, it seems to be very effective in the treatment of familial hypercholesterolemia.
Similar articles
-
Effects of probucol on xanthomata regression in familial hypercholesterolemia.Am J Cardiol. 1986 Jun 27;57(16):29H-35H. doi: 10.1016/0002-9149(86)90434-0. Am J Cardiol. 1986. PMID: 3728307
-
Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer.Am J Cardiol. 1988 Jul 25;62(3):66B-72B. doi: 10.1016/s0002-9149(88)80055-9. Am J Cardiol. 1988. PMID: 3394656
-
Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma.Atherosclerosis. 1999 Aug;145(2):405-13. doi: 10.1016/s0021-9150(99)00088-x. Atherosclerosis. 1999. PMID: 10488970
-
Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.Drugs. 1989 Jun;37(6):761-800. doi: 10.2165/00003495-198937060-00002. Drugs. 1989. PMID: 2667936 Review.
-
Treatment of familial and non-familial hypercholesterolaemia: a review of HMG-CoA reductase inhibitors and probucol.Eur Heart J. 1987 Aug;8 Suppl E:97-101. doi: 10.1093/eurheartj/8.suppl_e.97. Eur Heart J. 1987. PMID: 3315684 Review.
Cited by
-
Statins in homozygous familial hypercholesterolemia.Curr Atheroscler Rep. 2002 Jan;4(1):19-25. doi: 10.1007/s11883-002-0058-7. Curr Atheroscler Rep. 2002. PMID: 11772418 Review.
-
Guidance for Pediatric Familial Hypercholesterolemia 2017.J Atheroscler Thromb. 2018 Jun 1;25(6):539-553. doi: 10.5551/jat.CR002. Epub 2018 Feb 6. J Atheroscler Thromb. 2018. PMID: 29415907 Free PMC article.
-
The lipoproteins: predictors, protectors, and pathogens.Br Med J (Clin Res Ed). 1983 Oct 22;287(6400):1161-4. doi: 10.1136/bmj.287.6400.1161. Br Med J (Clin Res Ed). 1983. PMID: 6414611 Free PMC article. Review. No abstract available.
-
Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein.J Clin Invest. 1988 Mar;81(3):720-9. doi: 10.1172/JCI113377. J Clin Invest. 1988. PMID: 3125226 Free PMC article.
-
Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.Proc Natl Acad Sci U S A. 1987 Aug;84(16):5928-31. doi: 10.1073/pnas.84.16.5928. Proc Natl Acad Sci U S A. 1987. PMID: 3475709 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources